CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the JMP Securities Healthcare Conference on Wednesday, September 28, 2011 at 1:30 p.m. ET at The St. Regis New York.
